Novartis Doan's Hearing To Review FTC Ruling Set For Feb. 8

Oral arguments on Novartis' petition for review of the Federal Trade Commission's corrective advertising order for Doan's pills are scheduled to be heard in D.C. federal appeals court Feb. 8.